Hidradenitis suppurativa: the &quot;bright side&quot; of autoinflammation and hidden diseases by A.V. Marzano et al.




Title: Hidradenitis suppurativa: the “bright side” of autoinflammation and 
hidden diseases   
Paper code: G Ital Dermatol Venereol-6031 
Submission Date: 2018-04-05 18:27:27 





    Version: 1 
    Description: manoscritto originale 
    File format: application/msword 
 























































































































































 Dermatology Unit, Department of Pathophysiology and Transplantation, Università degli Studi di 
Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy 
 
2




Corresponding author:  
Angelo Valerio Marzano, MD 
Associate Professor Of Dermatology and Consultant, 
Dermatology Unit, Department of Pathophysiology and Transplantation, Università degli Studi di 
Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,  






Financial disclosure: none.  
The authors report no conflicts of interest. 












































































































































 Hidradenitis suppurativa (HS) is a chronic-relapsing, debilitating inflammatory disease primarily 
affecting the pilosebaceous unit.
1
 It is clinically characterized by recurrent, painful, deep-seated 
nodules, abscesses and sinus tracts ending in hypertrophic scarring that typically involve apocrine 
gland-rich areas of the body, notably axillary and inguinoperineal regions.
1
 HS is estimated to 
affect 1% of the population,
1
 but, in our opinion, the incidence and prevalence of the disease has 
significantly increased in the last few years. The pathophysiology of HS is the result of a complex 
interplay between genetic and environmental factors cross-talking with both innate and adaptive 
immunity dysfunction, as well-described in the review article by Napolitano et al.
2
, providing an 
update on HS pathogenesis. Heterozygous mutations in the γ-secretase genes – presenilin 
enhancer 2 (PSENEN), presenilin (PSEN1) and nicastrin - were the first reported genetic changes in 
HS.
3,4 
The above mutations cause inactivation of Notch signaling which is responsible for an 
altered homoeostasis of hair follicle and apocrine gland leading to the production of the so-called 
damage-associated molecular pattern (DAMP) molecules. These molecules induce an abnormal 
activation of the inflammasome, a molecular platform triggering the inflammatory process in HS 
as in the classic monogenic autoinflammatory diseases like familial Mediterranean fever.
5
 The 
important autoinflammatory component in the pathogenesis of the disease is supported also by 
the upregulation of interleukin(IL)-1β
6,7
, which is a pivotal cytokine in autoinflammation.
8
 On the 
other hand, some studies found γ-secretase mutations only in a minority of HS cases,
9,10 
suggesting 
γ-secretase mutation alone is not sufficient to produce the HS phenotype.
11
 Interestingly, our 
group reported mutations involving a number of autoinflammatory genes in the recently 
described syndromic variant of HS known as PASH (pyoderma gangrenosum, acne, suppurative 
hidradenitis), 
12,13
  giving rise to considering HS a polygenic autoinflammatory condition in which 
innate immunity dysfunction plays a key role. From an immunological point of view, IL-17, 
cytokine merging innate and adaptive immunity, has also been reported overexpressed in the 
lesional skin of HS.
14
 Of note, with respect to IL-1β and IL-17 expression, HS resembles PASH
15
 as 
well as two prototypic neutrophilic dermatoses, pyoderma gangrenosum and Sweet’s syndrome,
16
 
making justified, to include HS in the spectrum of neutrophilic dermatoses,
17 
based also on the 
high number of skin infiltrating neutrophils especially in later stages of the disease.
7
 The 
interesting article by Pescitelli et al.
18
 supports the recent view on HS as a systemic disease linked 
to several comorbidities, with which HS shares genetic factors, environmental triggers and 
inflammatory pathways. Reports of elevated circulating levels of tumour necrosis factor (TNF)-α
19
 
in HS are in line with systemic inflammatory activation. Obesity and metabolic syndrome are the 
most common associated conditions in HS patients
18





 also occur more frequently in these patients than in the 
general population. Thus, clinical intervention for HS must include consideration of these 
comorbidities and complications with a multidisciplinary approach that is outlined also in the 
article by Veraldi et al.
22
 Finally, the paper by Lacarrubba et al.
23
 reviews and discusses the 
important contributory role of imaging techniques, particularly ultrasonography.
24
 
Ultrasonography may reveal features not appreciable at clinical examination, notably fistulous 
tracts, allowing a more accurate staging, treatment planning and monitoring response to therapy 
in this debilitating disease.  
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